Laura Brege

Companies

• Edgewise Therapeutics, Inc.Board member Mar 25, 2021 to now¹
• Mirum PharmaceuticalsBoard member Jul 17, 2019 to now²
• Pacira BioSciences, Inc.Board member Jun 6, 2011 to now³
• Acadia PharmaceuticalsBoard member May 5, 2008 to now⁴
• DYNAVAX TECHNOLOGIES CORPBoard member Feb 9, 2015 to May 31, 2019⁵
• Delcath Systems, Inc.Board member Jul 9, 2012 to Jul 9, 2014⁶
• Onyx PharmaceuticalsEVP and Chief Business Officer Jun 13, 2006 to Oct 17, 2011⁷
• Onyx PharmaceuticalsChief operating officer Nov 10, 2010 to Jan 20, 2011⁸

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• MPMirum Pharmaceuticals MIRM15,703 shares⁹$1.3M at $82.39Sep 11, 2025
• PBPacira BioSciences, Inc. PCRX30,120 shares¹⁰$1.1M at $36.33Jun 10, 2026
• APAcadia Pharmaceuticals ACAD23,202 shares¹¹$443.6K at $19.12May 29, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 10, 2026Granted 6,405 shares of Pacira BioSciences, Inc.¹⁰
• May 29, 2026Exercised options 8,107 shares of Acadia Pharmaceuticals¹¹
• Sep 11, 2025Sold 1,491 shares at $75.07 of Mirum Pharmaceuticals⁹
• Sep 11, 2025Sold 15,509 shares at $74.34 of Mirum Pharmaceuticals⁹
• Sep 11, 2025Exercised options 17,000 shares at $15.00 of Mirum Pharmaceuticals⁹
• Jun 11, 2025Granted 6,163 shares of Pacira BioSciences, Inc.¹²
• Jun 4, 2025Sold 14,446 shares at $21.78 of Acadia Pharmaceuticals¹³
• May 29, 2025Exercised options 9,387 shares of Acadia Pharmaceuticals¹⁴
• May 29, 2025Exercised options 5,703 shares of Mirum Pharmaceuticals¹⁵
• Aug 16, 2024Bought 1,000 shares at $12.81 of Pacira BioSciences, Inc.¹⁶
• Jun 12, 2024Granted 5,230 shares of Pacira BioSciences, Inc.¹⁷
• May 29, 2024Exercised options 6,652 shares of Acadia Pharmaceuticals¹⁸
• Jun 14, 2023Granted 1,775 shares of Pacira BioSciences, Inc.¹⁹
• Jun 12, 2023Sold 4,500 shares at $24.87 of Acadia Pharmaceuticals²⁰
• Jun 5, 2023Sold 600 shares at $38.74 of Pacira BioSciences, Inc.²¹
• Jun 1, 2023Exercised options 8,552 shares of Acadia Pharmaceuticals²²
• Apr 3, 2023Sold 7,000 shares at $40.72 of Pacira BioSciences, Inc.²³
• Apr 3, 2023Exercised options 7,000 shares at $29.90 of Pacira BioSciences, Inc.²³
• Jan 12, 2023Sold 12,500 shares at $18.25 of Acadia Pharmaceuticals²⁴
• Jan 12, 2023Exercised options 12,500 shares at $17.01 of Acadia Pharmaceuticals²⁴
• Jun 8, 2022Granted 1,160 shares of Pacira BioSciences, Inc.²⁵
• Jun 7, 2022Exercised options 6,391 shares of Acadia Pharmaceuticals²²
• Jun 22, 2021Exercised options 3,059 shares of Acadia Pharmaceuticals²²